Sanofi, Kaiser Permanente, Providence Health & Services and Cigna all chipped in to help bring digital behavioural treatment developer Omada’s total funding to $200m.
Month: June 2019
Corporate venturing deal net: 24-28 June 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Redbee readies investment vehicle
Redbee has launched Venturebees with a $630,000 investment to back fintech, insurtech, marketing and digital media startups in Argentina.
Clearedin catches MS&AD as an investor
MS&AD Ventures participated in a $4.75m round for anti-phishing software startup Clearedin, which plans to invest the cash in recruitment.
BridgeBio crosses over to public markets with $349m
AIG scored an exit as genetic disease and cancer drug developer BridgeBio Pharma floated above its range while increasing the number of shares in its IPO.
Mitigram rallies in series B funding
Online trading risk platform Mitigram has raised $10.7m in the round, which included Mandatum Life and brought its total funding to $17.5m.
SpaceX spies $314m close for next round
The Alphabet-backed space launch services provider has raised cash from Ontario Teachers’ Pension Plan as it targets $314m at a likely $33.3bn pre-money valuation.
Adaptive Biotechnologies shapes $300m IPO
Shares in Adaptive Biotechnologies, backed by Microsoft, Celgene, Illumina, LabCorp and BD Biosciences, soared more than 100% on its first day of trading.
The RealReal realises IPO plans in $300m offering
Novel Group-backed luxury goods marketplace The RealReal will raise $300m in an initial public offering in which it will float above its range.
Greenstreet finds greener pastures in UK and Ireland
Ladi Greenstreet has left his US-based head of healthcare position at Accenture Ventures to become the unit’s head of UK and Ireland.
CFS sparks $115m series A close
Just over a year after securing an initial $50m, fusion energy technology developer Commonwealth Fusion Systems has closed its Eni-backed series A round with $115m in capital.
Encoded decrypts $104m in series C funding
Encoded Therapeutics, which was incubated in Illumina’s accelerator, has captured $104m in a series C round backed by the corporate’s strategic investment unit, Illumina Ventures.
Lundbeck signs up for Sanifit’s series D round
Cardiovascular drug developer Sanifit raised $82.1m including $62.8m from investors that included existing backer Lundbeckfonden Ventures to bring its overall financing to $149m.
Asahi Shimbun buys Bouncy
Nikkei, Gree, Globis, Dentsu and Yahoo Japan have exited video streaming platform Bouncy, which has been purchased by Asahi Shimbun for an undisclosed sum.